DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Brazil Generic Drug Market: Industry Trends, Share, Size, Growth, Forecast and Opportunity 2017-2022" report to their offering.
The report entitled Brazil Generic Drug Market: Industry Trends, Share, Size, Growth, Forecast and Opportunity 2017-2022 represents an in-depth analysis on the historical, current and future trends in the generic drug market in Brazil.
According to estimates, around BRL 2 Billion worth of branded drugs are expected to lose patent protection during the next five years. The high potential of generic drugs is also driven by the fact that despite strong growth in recent years, the penetration of generics still remains low compared to mature markets such as Germany, the United States, the United Kingdom, etc. These factors along with a rising ageing population, increasing prevalence of life style diseases and the significant cost savings achieved from the use of generic drugs are expected to drive this market during the next five years.
This research report serves as an exceptional tool to understand the drivers, sales trends, volume trends, market structure, competitive landscape, regulations, key players, manufacturing and the outlook of generic drugs in Brazil. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who want to gain an insight into the market for generic drugs in Brazil.
Key Topics Covered:
2 Research Methodology and Market Definitions
3 Executive Summary
4 Brazil Generic Drug Market - Introduction
5 Why is the Brazil Generic Drug Market So Lucrative
6 Global Generic Drug Market
7 Brazil Generic Drug Market
8 SWOT Analysis
9 Value Chain Analysis
10 Pricing Mechanism and Profit Margins at Various Levels of Supply Chain
11 Porter's Five Forces Analysis
12 Brazil Generic Drug Market: Competitive Landscape
13 Government Policy
14 Brazil Generic Drug Market: Key Success Factors
15 Brazil Generic Drug Market: Road Blocks
16 Generic Drug Manufacturing Process
17 Brazil Generic Drug Market: Key Company Profiles
- Ache Laboratories
- EMS S.A.
- Eurofarma Laboratórios S.A.
- Hypermarcas S.A.
- Sanofi Group
União Química Farmacêutica Nacional S.A
For more information about this report visit http://www.researchandmarkets.com/research/llp5b5/brazil_generic